AUGUST 2 0 2 1
ED I T I ON 8
Clinical Governance Standard
IS OPERATIONAL
NSLHD policies, procedures, guidelines, standing orders and NSW Health policy directives are now accessible via the Prompt documents system and to date, the staff feedback has been positive. Please continue to tell us what you think of Prompt.
In addition to the Prompt FAQs , there are a number of staff training resources available on the Policies & Procedures Intranet page and the message board on Prompt documents. These include the following:
A six minute Staff Training Video How to access and search for documents - Quick Reference Guide (QRG)
Prompt – Search Tips and Tricks Prompt – Phone or Tablet Access How to create hyperlinks to Prompt - QRG PPG Communique
Planned ongoing enhancements include creating a link from eMR to Prompt. Please contact email Nitisha.Bangera@health.nsw.gov.au for more information and to tell us what you think of Prompt documents.
POLICIES, PROCEDURES AND GUIDELINES New, updated and recent ly publ ished distr ict wide PPGs The fol lowing l inks to documents from the PROMPT document system.
Clinical Governance Standard
Clinical Governance Standard SAFETY ALERTS New , u p d a t e d a n d r e c e n t l y p u b l i s h e d SI:007/21 - Safe use of medications with multiple concentrations in Electronic Medication Management (EMM) systems- Issued 9 July SN:015/21 - Philips Sound Abatement Foam on selected sleep and respiratory devices – Product Defect Correction - Issued 5 July Admission and Discharge Criteria For NSLHD Subacute Inpatient Rehabilitation Units - NSLHD Bedrails Use of for Adult Inpatients NSLHD Methadone and Buprenorphine/Buprenorphine-Naloxone Prescribing and Dispensing for Opioid Dependent Inpatients of NSLHD Vitamin K (phytomenadione) administration in newborn infants - NSLHD Single Use of elastomeric infusion devices for the subcutaneous management of symptoms at end of life Treatment of hyperkalaemia in adult patients - NSLHD
SN:014/21 - 25C-NBOMe toxicity in patients who used powder thought to be MDMA - Issued 2 July SN:013/21 - Changes to COVID-19 vaccine access and indications (updated) - Issued 1 July SI:06/21 - Patient identity checks before administration of blood products - Issued 21 June SN:012/21 - Enoxaparin 20 mg and 40 mg syringes: Disruption to supply - Issued 1 June
Safety Alert (SA) - Requires immediate attention and action Safety Notice (SN) - Requires risk assessment at the district level Safety Information (SI) - Ensuring that lessons learned from state-wide, national or international sources are shared actively across NSW health system Medication Safety Updates Medication Safety Updates including medication shortages are available on the CEC website. Most recent medicines affected include Tocilizumab, Azathioprine injection (50mg), Nitrofurantoin, Etacrynic acid, Flucytosine and Promethazine
For more information, contact: NSLHD-SafetyAlert@health.nsw.gov.au
Made with FlippingBook - professional solution for displaying marketing and sales documents online